Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Pozycja w akcjach #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Cena akcji
$154.51
Kapitalizacja rynkowa
$55.98B
Zmiana (1 dzień)
-1.82%
Zmiana (1 rok)
-32.08%
Kraj
US
Handel Becton, Dickinson and Company (BDX)

Kategoria

Marża operacyjna dla Becton, Dickinson and Company (BDX)
Marża operacyjna na dzień March 2026 TTM: 12.40%
Według najnowszych raportów finansowych i ceny akcji Becton, Dickinson and Company, bieżąca marża operacyjna (TTM) wynosi 12.40%. Na koniec 2024 wynosiła 11.88%.
Historia marży operacyjnej dla Becton, Dickinson and Company od 2000 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) 12.40% 5.08%
2025 11.80% -0.67%
2024 11.88% 8.99%
2023 10.90% -9.84%
2022 12.09% 2.81%
2021 11.76% 107.41%
2020 5.67% -44.30%
2019 10.18% 7.84%
2018 9.44% -25.02%
2017 12.59% 9.86%
2016 11.46% 9.67%
2015 10.45% -45.03%
2014 19.01% 22.09%
2013 15.57% -22.96%
2012 20.21% -8.01%
2011 21.97% -1.08%
2010 22.21% -2.37%
2009 22.75% 4.74%
2008 21.72% 14.80%
2007 18.92% -4.88%
2006 19.89% 4.52%
2005 19.03% 19.31%
2004 15.95% -6.45%
2003 17.05% 0.12%
2002 17.03% -0.99%
2001 17.20% 8.72%
2000 15.82% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
29.27% -97.64%
US
16.22% -98.69%
DE
29.61% -97.61%
JP
13.08% -98.95%
CH
33.81% -97.27%
US
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.